TrialHaematologica2013

A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial.

Steven D Gore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.